|
| Exchange Disseminated Time | Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 30, 2015 to consider and approve the Company's Unaudited Financial Statements for the First Quarter ended June 30, 2015 (Q1).
Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on June 23, 2015 and will remain closed upto August 02, 2015 (both days inclusive) for the purpose of approval of Unaudited Financial Statements for the First Quarter ended June 30, 2015. |
|
|